Related Experiment Videos
Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group
M V Rocco1, M J Flanigan, S Beaver
1Department of Internal Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157-1053, USA. mrocco@bgsm.edu
Summary
This study on chronic ambulatory peritoneal dialysis (CAPD) patients found lower serum albumin and inadequate anemia and hypertension management. There
Area of Science:
- Nephrology
- Internal Medicine
- Public Health
Background:
- Chronic ambulatory peritoneal dialysis (CAPD) is a key treatment for end-stage renal disease.
- Assessing standard practices and outcomes in CAPD patients is crucial for improving care.
- Previous studies highlighted variability in CAPD patient management.
Purpose of the Study:
- To evaluate standard practices and patient outcomes in chronic peritoneal dialysis.
- To identify areas for improvement in the medical care of CAPD patients.
- To report on key indicators such as serum albumin, dialysis adequacy, anemia, and hypertension.
Main Methods:
- Analysis of data from 1,202 CAPD patients from November 1994 to April 1995.
- Measurement of serum albumin, weekly Kt/V(urea), and creatinine clearance.
- Assessment of hematocrit, recombinant human erythropoietin (rHmEPO) dosage, and blood pressure.
Main Results:
- Mean serum albumin was 3.5 g/dL (bromcresol green) or 3.2 g/dL (bromcresol purple).
- Dialysis adequacy (Kt/V or creatinine clearance) was available for only 34% of patients.
- Anemia (hematocrit < or = 30%) affected 50% of black and 31% of white patients; 29% had systolic BP >150 mmHg.
Conclusions:
- CAPD patients exhibited lower serum albumin levels compared to hemodialysis patients.
- A significant portion of CAPD patients lacked adequate monitoring for dialysis adequacy, anemia, and hypertension.
- There is a substantial opportunity to enhance the medical care provided to chronic peritoneal dialysis patients.